Anticoagulant plus antiplatelet therapy for atrial fibrillation

K Bode, G Hindricks, JM Ten Berg, P Whittaker - Herz, 2020 - search.proquest.com
Background Emerging evidence indicates combination therapy with anticoagulants and
antiplatelet agents for atrial fibrillation (AF) will be increasingly required. Numerous studies …
被引用次数：3 相关文章

Anticoagulant plus antiplatelet therapy for atrial fibrillation: Cost-utility of combination therapy with non-vitamin K oral anticoagulants vs. warfarin.

K Bode, G Hindricks, JM Ten Berg, P Whittaker - Herz, 2018 - europepmc.org
Background Emerging evidence indicates combination therapy with anticoagulants and
antiplatelet agents for atrial fibrillation (AF) will be increasingly required. Numerous studies …

Anticoagulant plus antiplatelet therapy for atrial fibrillation: Cost-utility of combination therapy with non-vitamin K oral anticoagulants vs. warfarin

K Bode, G Hindricks, JM Ten Berg, P Whittaker - Herz, 2020 - pubmed.ncbi.nlm.nih.gov
Background Emerging evidence indicates combination therapy with anticoagulants and
antiplatelet agents for atrial fibrillation (AF) will be increasingly required. Numerous studies …